A lipid carrier with a membrane active component and a small complex size are required for efficient cellular delivery of anti-sense phosphorothioate oligonucleotides

By Jaaskelainen I.   Peltola S.   Honkakoski P.   Monkkonen J.   Urtti A.  

European Journal of Pharmaceutical Sciences, Vol. 10, Iss. 3, 2000-05 ,pp. : 187-193

Elsevier

Access to resources Recommend Favorite

Toxicity and Relative Biological Effectiveness of Alpha Emitting Radioimmunoconjugates

By  

Current Radiopharmaceuticals, Vol. 4, Iss. 4, 2011-10 ,pp. : 321-328

Bentham Science Publishers

Access to resources Recommend Favorite

Animal models to assess the toxicity, immunogenicity and effectiveness of candidate influenza vaccines

By Eichelberger Maryna C   Green Martin D  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 9, 2011-09 ,pp. : 1117-1127

Informa Healthcare

Access to resources Recommend Favorite

Changes in Toxicity and Effectiveness with Timing of Drug Administration: Implications for Drug Safety

By Ohdo S.  

Drug Safety, Vol. 26, Iss. 14, 2003-01 ,pp. : 999-1010

Adis International

Access to resources Recommend Favorite

Integrated Simulation Framework for Toxicity, Dose Intensity, Disease Progression, and Cost Effectiveness for Castration‐Resistant Prostate Cancer Treatment With Eribulin

By  

Cpt: Pharmacometrics & Systems Pharmacology, Vol. 4, Iss. 7, 2015-08 ,pp. : 374-385

John Wiley & Sons Inc

Access to resources Recommend Favorite